02.05.2021

16:12

Early Detection of Aggressive Prostate Cancer

Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer

Uro Today

מן הרשת

02.05.2021

16:11

Cardiovascular Events in Men with Prostate Cancer Receiving Hormone Therapy

An Analysis of the FDA Adverse Event Reporting System (FAERS)

Uro Today

מן הרשת

02.05.2021

16:11

Molecular Biomarkers in Localized Prostate Cancer

ASCO Guideline

Journal of Clinical Oncology

מן הרשת

02.05.2021

16:09

Novel, non-invasive markers for detecting therapy induced neuroendocrine differentiation in castration-resistant prostate cancer patients

Uro Today

מן הרשת

02.05.2021

16:08

Active surveillance of metastatic renal cell carcinoma

Results from a prospective observational study (MaRCC)

Uro Today

מן הרשת

02.05.2021

16:08

First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma

A Systematic Review and Network Meta-analysis

Uro Today

מן הרשת

02.05.2021

16:07

Prognosis of Incidental Brain Metastases in Patients With Advanced Renal Cell Carcinoma

Uro Today

מן הרשת

02.05.2021

16:06

JNCCN Study Finds Important Potential Role for Routine Brain Imaging in Advanced Kidney Cancer

Uro Today

מן הרשת

02.05.2021

16:05

Radiation therapy for high-risk non-muscle invasive bladder cancer

Systematic review and meta-analysis

Uro Today

מן הרשת

02.05.2021

16:04

Clinical characterization of radiation-associated muscle-invasive bladder cancer

Uro Today

מן הרשת

02.05.2021

16:02

Optimal Pathologic Response After Neoadjuvant Chemotherapy For Muscle-Invasive Bladder Cancer

Results From A Global, Multi-Center Collaboration

Uro Today

מן הרשת

02.05.2021

16:01

Defining Cisplatin Eligibility in Patients with Muscle-Invasive Bladder Cancer - Beyond the Abstract

Uro Today

מן הרשת

02.05.2021

12:21

Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib

Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as a Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer

Takeda

מן הרשת

02.05.2021

12:19

Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as neoadjuvant treatment

CT003 - Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as neoadjuvant treatment (tx) for resectable (IB-IIIA) non-small cell lung cancer (NSCLC) in the phase 3 CheckMate 816 trial

American Association for Cancer Research

מן הרשת

02.05.2021

12:16

COVID-19 vaccine in patients with cancer

Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors

The Lancet Oncology

מן הרשת

Early Detection of Aggressive Prostate Cancer

Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer

Cardiovascular Events in Men with Prostate Cancer Receiving Hormone Therapy

An Analysis of the FDA Adverse Event Reporting System (FAERS)

Molecular Biomarkers in Localized Prostate Cancer

ASCO Guideline

Novel, non-invasive markers for detecting therapy induced neuroendocrine differentiation in castration-resistant prostate cancer patients

Active surveillance of metastatic renal cell carcinoma

Results from a prospective observational study (MaRCC)

First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma

A Systematic Review and Network Meta-analysis

Prognosis of Incidental Brain Metastases in Patients With Advanced Renal Cell Carcinoma

JNCCN Study Finds Important Potential Role for Routine Brain Imaging in Advanced Kidney Cancer

Radiation therapy for high-risk non-muscle invasive bladder cancer

Systematic review and meta-analysis

Clinical characterization of radiation-associated muscle-invasive bladder cancer

Optimal Pathologic Response After Neoadjuvant Chemotherapy For Muscle-Invasive Bladder Cancer

Results From A Global, Multi-Center Collaboration

Defining Cisplatin Eligibility in Patients with Muscle-Invasive Bladder Cancer - Beyond the Abstract

Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib

Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as a Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer

Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as neoadjuvant treatment

CT003 - Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as neoadjuvant treatment (tx) for resectable (IB-IIIA) non-small cell lung cancer (NSCLC) in the phase 3 CheckMate 816 trial

COVID-19 vaccine in patients with cancer

Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors

14.06.2021

מחקרים וחדשות רפואה

תגובות אחרונות

7 הכי נקראות